Correlation Between Aquestive Therapeutics and NeuroSense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on Aquestive Therapeutics and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and NeuroSense Therapeutics.
Diversification Opportunities for Aquestive Therapeutics and NeuroSense Therapeutics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aquestive and NeuroSense is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and NeuroSense Therapeutics go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and NeuroSense Therapeutics
Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the NeuroSense Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Aquestive Therapeutics is 5.27 times less risky than NeuroSense Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The NeuroSense Therapeutics Ltd is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 25.00 in NeuroSense Therapeutics Ltd on December 5, 2024 and sell it today you would lose (4.00) from holding NeuroSense Therapeutics Ltd or give up 16.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Aquestive Therapeutics vs. NeuroSense Therapeutics Ltd
Performance |
Timeline |
Aquestive Therapeutics |
NeuroSense Therapeutics |
Aquestive Therapeutics and NeuroSense Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aquestive Therapeutics and NeuroSense Therapeutics
The main advantage of trading using opposite Aquestive Therapeutics and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
NeuroSense Therapeutics vs. Neurosense Therapeutics | NeuroSense Therapeutics vs. GeoVax Labs | NeuroSense Therapeutics vs. NLS Pharmaceutics AG | NeuroSense Therapeutics vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |